Baseline characteristics
| Characteristic | Device Group (n = 475) | Manual-Compression Group (n = 79) | P Value |
|---|---|---|---|
| Male/Female | 197 (41)/278 (59) | 30 (38)/49 (62) | >.05 |
| Age (years)a | 58.8 ± 14.4 | 50.1 ± 17.0 | <.0001 |
| Diabetes | 108 (23) | 3 (3.8) | <.0001 |
| Coronary artery disease | 84 (18) | 10 (13) | >.05 |
| TIA/CVA | 184 (39) | 8 (10) | <.0001 |
| Preprocedural drug | |||
| Heparin | 104 (22) | 5 (6.3) | .0013 |
| Abciximab | 14 (2.9) | 0 | >.05 |
| Aspirin/clopidogrel | 268 (56) | 12 (15) | <.0001 |
| Previous device procedures | |||
| 0 | 337 (71) | 54 (68) | >.05 |
| 1 | 90 (19) | 15 (19) | >.05 |
| 2 | 34 (7.2) | 8 (10) | >.05 |
| 3 | 9 (1.9) | 1 (1.3) | >.05 |
| 4 | 4 (0.8) | 0 | >.05 |
| 5 | 1 (0.2) | 1 (1.3) | >.05 |
Note.—Data in parentheses are percentages.
a Mean ± standard deviation.